These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12965259)

  • 1. No evidence for direct modulatory effects of delta 9-tetrahydrocannabinol on human polymorphonuclear leukocytes.
    Deusch E; Kraft B; Nahlik G; Weigl L; Hohenegger M; Kress HG
    J Neuroimmunol; 2003 Aug; 141(1-2):99-103. PubMed ID: 12965259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
    Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
    Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells.
    Rao GK; Zhang W; Kaminski NE
    J Leukoc Biol; 2004 May; 75(5):884-92. PubMed ID: 14966196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro immunomodulatory effects of sulfasalazine on human polymorphonuclear leukocytes, mononuclear cells, and cultured glomerular mesangial cells.
    Tsai CY; Wu TH; Yu CL; Chou CT
    Life Sci; 2000; 67(10):1149-61. PubMed ID: 10954049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effect of delta 9-tetrahydrocannabinol on human neutrophil function.
    Djeu JY; Wang M; Friedman H
    Adv Exp Med Biol; 1991; 288():57-62. PubMed ID: 1659138
    [No Abstract]   [Full Text] [Related]  

  • 6. Δ
    Shang VC; Kendall DA; Roberts RE
    Biochem Pharmacol; 2016 Nov; 120():63-71. PubMed ID: 27641813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamide.
    Kraft B; Wintersberger W; Kress HG
    Life Sci; 2004 Jul; 75(8):969-77. PubMed ID: 15193957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids and the human uterus during pregnancy.
    Dennedy MC; Friel AM; Houlihan DD; Broderick VM; Smith T; Morrison JJ
    Am J Obstet Gynecol; 2004 Jan; 190(1):2-9; discussion 3A. PubMed ID: 14749627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids.
    Petroni KC; Shen L; Guyre PM
    J Immunol; 1988 May; 140(10):3467-72. PubMed ID: 2966197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Δ-Tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: involvement of cannabinoid receptor 2 and p38 MAPK.
    Yamaori S; Ishii H; Chiba K; Yamamoto I; Watanabe K
    Toxicology; 2013 Dec; 314(2-3):254-61. PubMed ID: 24184660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Δ
    Prester L; Mikolić A; Jurič A; Fuchs N; Neuberg M; Lucić Vrdoljak A; Brčić Karačonji I
    Chem Biol Interact; 2018 Oct; 294():128-134. PubMed ID: 30130528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.
    Xie J; Xiao D; Xu Y; Zhao J; Jiang L; Hu X; Zhang Y; Yu L
    Oncotarget; 2016 Feb; 7(6):6436-47. PubMed ID: 26824325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme.
    Hernández M; Berrendero F; Suárez I; García-Gil L; Cebeira M; Mackie K; Ramos JA; Fernández-Ruiz J
    Brain Res; 2000 Feb; 857(1-2):56-65. PubMed ID: 10700552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.
    Darmani NA
    Pharmacol Biochem Behav; 2001 Feb; 68(2):311-7. PubMed ID: 11267636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Zhong W; Trinh C; McClanahan B; Brar RS
    Eur J Pharmacol; 2014 Jan; 722():147-55. PubMed ID: 24157976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    Takeda S; Jiang R; Aramaki H; Imoto M; Toda A; Eyanagi R; Amamoto T; Yamamoto I; Watanabe K
    J Pharm Sci; 2011 Mar; 100(3):1206-11. PubMed ID: 20891010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.